One year after a six‑part pledge aimed at easing prior authorization was announced, insurers are now saying they will not fully honor the commitments, and patients continue to face delays and denials.
Insurers report modest cuts, critics remain unconvinced
The health‑insurance trade group AHIP says its members have eliminated 6.5 million prior authorizations since the pledge, an 11 % drop. The reduction, however, applies only to medical services, not prescription drugs, and the group did not break down which procedures were affected.
“In the absence of clear rules, policies, standards, and mandates,” said Sabrina Corlette, a research professor at Georgetown University’s Center on Health Insurance Reforms, “insurance companies are going to do what makes sense for them financially.” The lack of enforceable standards leaves the industry largely self‑policing.
Real‑world impact: families still wrestle with out‑of‑network charges
In Minnesota, the family of newborn Coco Young discovered that despite switching to Medica as part of the pledge, the insurer processed many claims as out‑of‑network. By March, they had accrued more than $4,000 in out‑of‑network charges plus $3,000 in‑network bills. When the mother, psychotherapist Betsy Adler, called for clarification, a representative said a required referral had not been submitted, then later claimed the insurer’s fax machine was down.
Related: The Strategic Framework for High-Impact Clinical Briefing
Medica declined to comment on the specific case, citing patient privacy, but issued a statement affirming its “commitment to working with her to ensure she understands what is covered under her benefits and our responsibilities.”
From a practical standpoint, the uneven application of the pledge means families must manage extensive paperwork, often with little guidance. When insurers change network status without clear notice, patients can be forced to choose between costly out‑of‑pocket expenses and delaying essential care.
Legislative and regulatory response
Congress is moving on the issue. The House Ways and Means Committee advanced a bill requiring Medicare Advantage plans to submit a list of all services subject to prior authorization and to report denial data. The legislation aims to add transparency that the industry’s voluntary pledge has not provided.
During the original announcement, then‑CMS administrator Mehmet Oz warned of “violence in the streets” over prior‑authorization practices and promised “public dashboards” to track progress. No such dashboards exist, and the Department of Health and Human Services has not responded to inquiries about accountability.
Related: Insurers Pocket Discounts Meant for Patients
Industry perspective and next steps
AHIP’s spokesperson Chris Bond maintains that prior authorization is “a vital patient safeguard” that helps control costs and prevent waste. He acknowledges that “there is still significant work ahead” and says health plans are “working continuously to implement their commitments to simplify and improve the experience.”
Health Access Innovation founder Mike Gartner doubts the impact of the 11 % reduction, noting that it “hides a lot of nuance.” He points out that patients needing the most expensive services, such as cancer treatment, continue to face disproportionate denials.
While the pledge was intended as a response to public anger, the lack of binding enforcement and the continued reliance on paper‑based or faxed requests suggest that meaningful change remains elusive.
